alexa Beta-tubulin Isotype 1 Conferred Benzimidazole-resistance in Lymphatic Filariasis: an Explanation by Molecular Concern | Open Access Journals
ISSN: 2165-7831
Journal of Blood & Lymph
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Beta-tubulin Isotype 1 Conferred Benzimidazole-resistance in Lymphatic Filariasis: an Explanation by Molecular Concern

Viroj Wiwanitkit*

Department of Medicine, Hainan Medical University, Hainan Sheng, PR China

*Corresponding Author:
Wiwanitkit V
Hainan Medical University
Hainan Sheng, PR China
Tel: +86 898 6689 3610
E-mail: [email protected]

Received Date: August 03, 2017; Accepted Date: August 14, 2017; Published Date: August 24, 2017

Citation: Wiwanitkit V (2017) Beta-tubulin Isotype 1 Conferred Benzimidazoleresistance in Lymphatic Filariasis: an Explanation by Molecular Concern. J Blood Lymph 7: e123. doi: 10.4172/2165-7831.1000e123

Copyright: © 2017 Wiwanitkit V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Blood & Lymph

The lymphatic filariasis is an important lymphatic disease. It is the well-known lymphatic vessel disorder due to infection by a blood parasitic pathogen. The nematode parasite transmitted by mosquito is the cause of filariasis which can further result in severe disability in chronic infected cases. The filariasis is accepted as an important but forgotten tropical mosquito borne infection. The disease can be chronic and result in permanent disability, the elephantaiasis. At present, this disease is still endemic in several tropical regions around the world. The management of filiariasis can be by using antiparasitic drug. The Albendazole, anthelmintic benzimidazole (BZ) is generally used concomitant with diethylcarbamazine, in lymphatic filariasis management. Schwab et al. mentioned that “The Global Program for the Elimination of Lymphatic Filariasis intends to achieve its aims through yearly mass treatments with BZ combined with ivermectin (IVM) or diethylcarbamazine (DEC) [1].”

However, the resistance to BZ can be observed in clinical practice. The role of genetic polymorphism underlying the BZ resistance is of interest. There are some reports mentioning for some genetic polymorphisms of the parasite that can contribute to resistance to NZ. The mutation that results in replacement of phenylalanine (Phe) with tyrosine (Tyr) at position 200 of beta-tubulin isotype 1 is reported to be related to resistance to BZ [2,3]. As noted by Hoti et al. monitoring of this point genetic variant is suggested for monitoring of drug resistance of filariasis in endemic area [2]. The observed pattern of the mutation in each setting can refer to the drug resistance epidemiology in each specific area and can also a predictor for the success of treatment. The available PCR tool can be applied for such investigation of the mutation that can confer to the BZ resistance of the filarial pathogen [3]. Cobo concludes that “widespread of resistance to BZ is present because specific mutations in the gene encoding β-tubulin have been associated with drug resistance [4].”

The mechanism conferring to the resistance is very interesting. Here, the author used the quantum molecular approach for explanation for the observed resistance due to the mentioned mutation. Briefly, when the mentioned mutation, 200 Phe -> Tyr occurs, the molecular change from naïve molecule of beta-tubulin isotype 1 can be expected. The quantum calculation for the molecular weight change can be done and the derived change magnitude is 16 Da per mol. As described in previous similar studies on quantum molecular estimation for the genetic variant change in other disorders [5-8], the change in the present scenario of beta-tubulin isotype 1 can also affect the final pharmaco-biological process between BZ drug and filarial parasite. The increased molecular weight can imply more required molecular reaction energy between drug and parasite. This can further results in increased difficulty in successful drug pharmacological action. Hence, the mentioned 200 Phe ->Tyr mutation of beta-tubulin isotype 1 can pose resistance property to BZ. This short study can well clarify the myth about the resistance to BZ of tropical filarial parasite, which is still the problem in management of filiarisis at present [9].

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 46
  • [From(publication date):
    September-2017 - Sep 23, 2017]
  • Breakdown by view type
  • HTML page views : 29
  • PDF downloads :17
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords